Collegium Pharmaceutical Inc
Collegium is a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. Collegium’s headquarters are located in Stoughton, Massachusetts.
Current Price
$33.78
-3.01%GoodMoat Value
$106.16
214.3% undervaluedCollegium Pharmaceutical Inc (COLL) financial data including income statement, balance sheet, and cash flow statement. This page provides a comprehensive view of Collegium Pharmaceutical Inc's financial performance and position as a Healthcare company.
Trailing twelve-month (TTM) revenue is $796.33M. Gross profit (TTM) is $483.18M. EBITDA is $189.18M. Earnings per share (EPS) is $1.73. The P/E ratio is 14.31. Market capitalization is $1.07B.
Free cash flow (FCF) is $327.58M. FCF growth rate is 50.00%. EPS growth CAGR is 18.64%. Weighted average cost of capital (WACC) is 10.00%.
Historical revenue data covers 7 years from FY19 to FY25. Net income history spans 7 years. Free cash flow and capital expenditure data spans 7 years. GoodMoat displays interactive charts for revenue, net income, FCF vs CAPEX, and cash-to-debt ratios to help investors identify financial trends.
Use Collegium Pharmaceutical Inc's financial data to assess the company's earnings quality, balance sheet health, and cash generation. Compare key metrics across periods to identify trends before making investment decisions with GoodMoat's valuation tools.
